A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

A survey of the effectiveness of centralized consilia in providing advice on drug-resistant TB

Saved in:

Bibliographic Details
Main Authors:	A. Vasquez, C. Mitnick, A.U. Nyaruhirira, C-Y. Chiang, C.R. Horsburgh
Format:	Article
Language:	English
Published:	International Union Against Tuberculosis and Lung Disease (The Union) 2024-07-01
Series:	IJTLD Open
Subjects:	tuberculosis, multi-drug resistant tuberculosis mdr-tb rifampicin-resistant tb rr-tb consilia
Online Access:	https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000007/art00010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01)

TB and poverty: the effect of rifampicin-resistant TB on household income
by: A. Ciobanu, et al.
Published: (2024-04-01)

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland
by: A. Nowinski, et al.
Published: (2025-01-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

The implementation of whole-genome sequencing for Mycobacterium tuberculosis in Vietnam
by: D.T. Huong, et al.
Published: (2024-07-01)

The TB burden in East Java, Indonesia, post-COVID-19
by: S. Palupi, et al.
Published: (2024-08-01)

Time to be seen and heard: Including children’s and adolescents’ voices in the South African TB response
by: C Goslett, et al.
Published: (2024-07-01)

TB prevention activities in the WHO European Region
by: A. Matteelli, et al.
Published: (2024-08-01)

Mapping TB incidence across districts in Uganda to inform health program activities
by: N.J. Henry, et al.
Published: (2024-05-01)

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01)

TB drug susceptibility testing in high fluoroquinolone resistance settings
by: F. Saluzzo, et al.
Published: (2024-05-01)

Prevalence of TB-related symptoms and self-reported disability among adult TB survivors
by: A.K. McDonald, et al.
Published: (2024-12-01)

Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova
by: A. Ciobanu, et al.
Published: (2024-06-01)

Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01)

Analytical and clinical validation of a novel MeltPlus TB-NTM/RIF platform for simultaneous detection of Mycobacterium tuberculosis complex, Non-Tuberculous Mycobacteria and rifampicin resistance
by: Zhuo Wang, et al.
Published: (2025-02-01)

3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients
by: A. Kinikar, et al.
Published: (2024-09-01)

Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study
by: Salvatore Rotundo, et al.
Published: (2025-02-01)

Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)

Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
by: A.J. Marthinus, et al.
Published: (2025-01-01)

Real-life use of delamanid: results from the European post-authorisation safety study
by: N. Schönfeld, et al.
Published: (2024-06-01)

Missed rifampicin and isoniazid resistance by commercial molecular assays
by: L Richards, et al.
Published: (2024-07-01)

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020
by: M.L. Rekart, et al.
Published: (2024-07-01)

More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)

Commitment, partnerships and operational research: three priorities for 11 EMR countries to achieve TB elimination
by: M. van den Boom, et al.
Published: (2024-01-01)

Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
by: S. Verkuijl, et al.
Published: (2024-01-01)

Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan
by: S. Moe, et al.
Published: (2024-09-01)

Modeling TB and HIV co-infections
by: Lih-Ing W. Roeger, et al.
Published: (2009-08-01)

Pancreatic tuberculosis mimicking as pancreatic malignancy: Surgeon's dilemma
by: Rohik Anjum T. Siddeek, et al.
Published: (2023-07-01)

Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01)

Theoretical assessment of the relative incidences of sensitive andresistant tuberculosis epidemic in presence of drug treatment
by: Silvia Martorano Raimundo, et al.
Published: (2014-02-01)

Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal
by: Madan Singh Bohara
Published: (2025-02-01)

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals
by: B. Muriithi, et al.
Published: (2025-01-01)

Burden and challenges in managing TB infection among people with occupational exposure to silica in India
by: B. Kalottee, et al.
Published: (2024-11-01)

Stool Xpert® MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme
by: S. Kabir, et al.
Published: (2024-10-01)

Knowledge, Attitude, and Stigma on Tuberculosis and the Associated Factors for Attitude Among Tuberculosis Contacts in Malaysia
by: Shin Yee LOH, et al.
Published: (2023-03-01)

Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa
by: J-D K Lotz, et al.
Published: (2023-11-01)

The intersection of TB and health financing: defining needs and opportunities
by: W.A. Wells, et al.
Published: (2024-09-01)

Gambaran Tingkat Kepatuhan Pengobatan Pasien TB Paru
by: Endang Martini, et al.
Published: (2024-10-01)

Sputum availability and quality in country-level TB prevalence surveys
by: P. Papadopoulou, et al.
Published: (2024-11-01)

Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings
by: M. Mbenga, et al.
Published: (2024-04-01)